Effect of botulinum toxin type A on muscular temporomandibular disorder: A systematic review and meta-analysis of randomized controlled trials.
Kaiyang LiKenneth TanAlexandra YacovelliWei Guang BiPublished in: Journal of oral rehabilitation (2023)
BTX-A is a safe and effective treatment for reducing pain and improving temporomandibular muscle and joint function in muscular TMD patients. A bilateral dose of 60-100 U might be an optimal choice for treating muscular TMD pain.
Keyphrases
- botulinum toxin
- chronic pain
- end stage renal disease
- resistance training
- pain management
- neuropathic pain
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- skeletal muscle
- spinal cord
- spinal cord injury
- body composition
- patient reported outcomes
- case report
- combination therapy
- high intensity